elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38749151-658B9AD6-C1E8-4369-BC21-F908BCFC2FB0
Q38749151-658B9AD6-C1E8-4369-BC21-F908BCFC2FB0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38749151-658B9AD6-C1E8-4369-BC21-F908BCFC2FB0
Targeting the MDM2-p53 Protein-Protein Interaction for New Cancer Therapy: Progress and Challenges.
P2860
Q38749151-658B9AD6-C1E8-4369-BC21-F908BCFC2FB0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38749151-658B9AD6-C1E8-4369-BC21-F908BCFC2FB0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0d3d98931f0613e8c0cdf0798b55ef0b50da2e20
P2860
Discovery of a Dihydroisoquinolinone Derivative (NVP-CGM097): A Highly Potent and Selective MDM2 Inhibitor Undergoing Phase 1 Clinical Trials in p53wt Tumors